Assertio to present new data from real-world evidence study of sympazan® at upcoming 150th annual meeting of the american neurological association

Lake forest, ill., sept. 10, 2025 (globe newswire) -- assertio holdings, inc. (“assertio” or the “company”) (nasdaq: asrt), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients' needs, today announced that the company will present new data for sympazan (clobazam) oral film in a poster presentation at the 150th annual meeting of the american neurological association (ana2025), september 13-16, 2025, baltimore marriott waterfront, baltimore.
ASRT Ratings Summary
ASRT Quant Ranking